Segal, L. N., Clemente, J. C., Wu, B. G., Wikoff, W. R., Gao, Z., Li, Y., . . . Weiden, M. D. (2017). Randomised, double-blind, placebo-controlled trial with azithromycin selects for anti-inflammatory microbial metabolites in the emphysematous lung. Thorax.
Chicago-stil citatSegal, Leopoldo N., et al. "Randomised, Double-blind, Placebo-controlled Trial With Azithromycin Selects for Anti-inflammatory Microbial Metabolites in the Emphysematous Lung." Thorax 2017.
MLA-referensSegal, Leopoldo N., et al. "Randomised, Double-blind, Placebo-controlled Trial With Azithromycin Selects for Anti-inflammatory Microbial Metabolites in the Emphysematous Lung." Thorax 2017.
Varning: dessa hänvisningar är inte alltid fullständigt riktiga.